IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,070,939 | +369.5% | 184,187 | +132.0% | 0.05% | +420.0% |
Q2 2023 | $1,505,997 | -36.9% | 79,388 | -48.4% | 0.01% | -33.3% |
Q1 2023 | $2,385,726 | +57.3% | 153,819 | +80.0% | 0.02% | +66.7% |
Q4 2022 | $1,516,525 | +689.9% | 85,438 | +148.1% | 0.01% | +800.0% |
Q3 2022 | $192,000 | +74.5% | 34,431 | +22.2% | 0.00% | 0.0% |
Q2 2022 | $110,000 | -50.0% | 28,167 | -29.5% | 0.00% | -50.0% |
Q1 2022 | $220,000 | -62.0% | 39,932 | -41.2% | 0.00% | -66.7% |
Q4 2021 | $579,000 | -46.1% | 67,944 | -45.0% | 0.01% | -57.1% |
Q3 2021 | $1,074,000 | +95.6% | 123,602 | +138.0% | 0.01% | +133.3% |
Q2 2021 | $549,000 | -74.2% | 51,933 | -60.9% | 0.01% | -77.8% |
Q1 2021 | $2,129,000 | +327.5% | 132,741 | +1132.2% | 0.03% | +285.7% |
Q4 2020 | $498,000 | -42.8% | 10,773 | -56.4% | 0.01% | -46.2% |
Q3 2020 | $870,000 | +698.2% | 24,729 | +450.9% | 0.01% | +550.0% |
Q2 2020 | $109,000 | +2080.0% | 4,489 | +1224.2% | 0.00% | – |
Q1 2020 | $5,000 | – | 339 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |